A study to assess the pharmacokinetics, and glucodynamics of LY3209590 in participants with type 2 diabetes
I8H-MC-BDDG
Phase 1 other active
Quick answer
A study to assess the pharmacokinetics, and glucodynamics of LY3209590 in participants with type 2 diabetes for Type 2 Diabetes Mellitus is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Modality
- other
- Status
- active